Court Strikes Down HRSA’s 340B Orphan Drug Policy, Again
In October, a federal court struck down a Health Resources and Services Administration 340B orphan drug policy (the…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Both Houses of Congress Investigating Prescription Drug Prices
There have been numerous media reports referencing dramatic drug price increases after the acquisition or merger of…
Off-label Marketing is “Dead,” Diversion Cases on the Rise
"Off-label marketing is dead so-to-speak. There's been a death knell of that."
That news was delivered by Charlene…
HHS OIG Issues 2016 Work Plan
The Department of Health and Human Services Office of Inspector General recently released its 2016 Work Plan. OIG's…
Amarin Update – The Case of Many Cases
There are currently two cases working their way through the legal system relating to Amarin and their quest for exclusivity and…
Pacira Update: A Settlement in the Works?
As we have previously written, the FDA has recently removed the Pacira warning letter from their website, which set off a…
Massachusetts Physician Arrested and Indicted for Kickbacks from Warner…
Last week, in addition to the President of Warner Chilcott being arrested and the company pleading guilty to Medicare…
Third Circuit Allows RICO Suit Against GlaxoSmithKline to Proceed
Recently, the United States Court of Appeals for the Third Circuit allowed a group of third party payors, including…
DOJ: Nearly 500 Hospitals Pay United States Over $250 Million to Resolve…
The Department of Justice announced on Friday, October 30, that they have reached 70 individual settlements involving…
Warner Chilcott Pleads Guilty to Healthcare Fraud Pays $125 Million Fine…
Warner Chilcott has agreed to plead guilty to healthcare fraud and will pay the government $125 million to settle both…